Skip to main content
Premium Trial:

Request an Annual Quote

Open Access on the 'Horizon?'

Negotiations are proceeding as the European Commission debates the details of its new €80 billion, seven-year research funding program Horizon 2020, says ScienceInsider's Jop de Vrieze. One of the points being discussed is how committed the Commission is to making open access to research a part of the program's rules. The Commission's director-general of research and innovation, Robert-Jan Smits, has said that research papers funded by Horizon 2020 — which runs from 2014 through 2020 — will be available through open-access channels within six months to a year of publication.

But the Commission currently has no power to make sure scientists follow this rule, de Vrieze says. And journal publishers are already complaining that six months is nowhere near enough time to cover publishing expenses before the papers become freely available. "We are open to any model, as long as it is sustainable," says Elsevier's Alicia Wise. "That means, the health of the journal is OK and the costs that are made are reimbursed."

The debate is currently unfolding in Brussels, de Vrieze adds, where publishers are lobbying hard to secure their interests, but Smits says the Commission will be guided by what's good for science and not by lobbying.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.